House Committee Investigates Pfizer COVID Vaccine Delay Influence 2020 Election

The House Judiciary Committee is investigating allegations that Pfizer deliberately delayed the release of positive COVID-19 vaccine trial results to influence the 2020 U.S. presidential election. The inquiry centers on Philip Dormitzer, Pfizer’s former Global Head of Vaccines Research and Development, who reportedly told colleagues at GSK that senior Pfizer executives conspired to slow clinical testing so results would not be available before the election. Dormitzer sought a transfer to Canada due to fears of investigation by the incoming Trump administration, suggesting the vaccine timing was not coincidental. Pfizer’s vaccine trial results were announced five days after the 2020 election, and the Committee has demanded documents and interviews to clarify the delay and motivations. Pfizer has denied delaying the disclosure of completed results but acknowledged a slowdown in testing prior to disclosure. These allegations have raised serious concerns about corporate ethics, political influence on public health data, and potential manipulation of the election.